Terpenoid ID | TKC020732 | |
Chirality | TKC130223 | |
Cell line | 0 | |
Protein target | 6 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 57 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC020732 | HOP-18 | HOP 18; Hop 18; HOP18; Hop18; Hopkins-18 | 100000.0 | nM | GI50 | C4450 | |
TKC020732 | SN12C | SN-12C | 893305.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020732 | ACHN | 870964.0 | nM | GI50 | C6975 | Orphanet_319298 | |
TKC020732 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 933254.0 | nM | GI50 | C3512 | |
TKC020732 | UO-31 | UO.31; UO31; U031 | 924698.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020732 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 841395.0 | nM | GI50 | C2926 | |
TKC020732 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 816582.0 | nM | GI50 | C9154 | Orphanet_519 |
TKC020732 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 899498.0 | nM | GI50 | C3796 | Orphanet_251576 |
TKC020732 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 885116.0 | nM | GI50 | C3224 | |
TKC020732 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 849180.0 | nM | GI50 | C3510 | |
TKC020732 | A498 | A498 | 905733.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020732 | K562 | K562; K.562; K 562; KO; GM05372; GM05372E | 812831.0 | nM | GI50 | C9110 | Orphanet_521 |
TKC020732 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 891251.0 | nM | GI50 | C105555 | |
TKC020732 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 1137627.0 | nM | GI50 | C9142 | Orphanet_99861 |
TKC020732 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 883080.0 | nM | GI50 | C3512 | |
TKC020732 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 787046.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC020732 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 968278.0 | nM | GI50 | C105555 | |
TKC020732 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 1044720.0 | nM | GI50 | C105555 | |
TKC020732 | DMS-273 | DMS-273; DMS273; Darmouth Medical School 273 | 993116.0 | nM | GI50 | C4917 | Orphanet_70573 |
TKC020732 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 905733.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC020732 | TK-10 | TK.10; TK 10; TK10 | 1004616.0 | nM | GI50 | C4033 | Orphanet_319276 |
TKC020732 | SR | SR-786; SR786 | 889201.0 | nM | GI50 | C37193 | Orphanet_300895 |
TKC020732 | M19-MEL | M-19; M19 | 879023.0 | nM | GI50 | C3802 | |
TKC020732 | SW-620 | SW-620; SW 620; SW.620 | 895365.0 | nM | GI50 | C4349 | |
TKC020732 | KM12 | KM-12; KM.12 | 1023293.0 | nM | GI50 | C4910 | |
TKC020732 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 988553.0 | nM | GI50 | C3512 | |
TKC020732 | XF498 | XF-498; XF498 | 993116.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020732 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 893305.0 | nM | GI50 | C3802 | |
TKC020732 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 100000.0 | nM | GI50 | C3242 | Orphanet_29073 |
TKC020732 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 968278.0 | nM | GI50 | C2923 | |
TKC020732 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 963829.0 | nM | GI50 | C105555 | |
TKC020732 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 897429.0 | nM | GI50 | C3802 | |
TKC020732 | KM-20L2 | KM-20L2; KM 20L2; KM 2012 | 903649.0 | nM | GI50 | C4349 | |
TKC020732 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 797995.0 | nM | GI50 | C3224 | |
TKC020732 | A549 | 968278.0 | nM | GI50 | C3512 | ||
TKC020732 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 972747.0 | nM | GI50 | C4349 | |
TKC020732 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 864968.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020732 | HCT-15 | HCT-15; HCT.15; HCT15 | 891251.0 | nM | GI50 | C4349 | |
TKC020732 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 922571.0 | nM | GI50 | C4910 | |
TKC020732 | SF-268 | SF-268; SF.268; SF 268 | 944061.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC020732 | EKVX | 1030386.0 | nM | GI50 | C3512 | ||
TKC020732 | DMS-114 | DMS-114; DMS114; Darmouth Medical School 114 | 891251.0 | nM | GI50 | C4917 | Orphanet_70573 |
TKC020732 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 1135011.0 | nM | GI50 | C7978 | |
TKC020732 | LXFL 529 | LXFL-529L; LXFL529L; LXF 529 L; LXFL-529; LXFL 529; LXFL529; LXF 529 | 855067.0 | nM | GI50 | C2926 | |
TKC020732 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 968278.0 | nM | GI50 | C4450 | |
TKC020732 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 837529.0 | nM | GI50 | C3224 | |
TKC020732 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 935406.0 | nM | GI50 | C3224 | |
TKC020732 | SF-295 | SF-295; SF.295; SF 295 | 924698.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020732 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 993116.0 | nM | GI50 | C7979 | Orphanet_454723 |
TKC020732 | RXF 631 | RXF-631L; RXF631L; RXF 631; RXF-631; RXF631 | 907821.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020732 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 922571.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020732 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 926830.0 | nM | GI50 | C3224 | |
TKC020732 | SNB-78 | SNB78; Surgical Neurology Branch-78 | 986279.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC020732 | DLD-1 | DLD 1; DLD1; CoCL3 | 885116.0 | nM | GI50 | C4349 | |
TKC020732 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 826038.0 | nM | GI50 | C7953 | Orphanet_99861 |
TKC020732 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 829851.0 | nM | GI50 | C45662 | Orphanet_50251 |
TKC020732 | HT-29 | HT 29; HT29 | 922571.0 | nM | GI50 | C4349 | |
TKC020732 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 950605.0 | nM | GI50 | C3510 | |
TKC020732 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 981748.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC020732 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 1006932.0 | nM | GI50 | C4349 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC020732 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 630957 | nM | Potency |
TKC020732 | P10828 | Thyroid hormone receptor beta | THRB | 794328 | nM | Potency |
TKC020732 | P02545 | Prelamin-A/C | LMNA | 794 | nM | Potency |
TKC020732 | Q03181 | Peroxisome proliferator-activated receptor delta | PPARD | 1258925 | nM | Potency |
TKC020732 | P19793 | Retinoic acid receptor RXR-alpha | RXRA | 1258925 | nM | Potency |
TKC020732 | P04637 | Cellular tumor antigen p53 | TP53 | 3162 | nM | Potency |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P10828 | THB_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
P10828 | THB_HUMAN | Hypo-thyroidism [ICD-11: 5A00] |
P10828 | THB_HUMAN | Inborn lipid metabolism error [ICD-11: 5C52] |
P10828 | THB_HUMAN | Skin postprocedural disorder [ICD-11: EL8Y] |
P10828 | THB_HUMAN | Thyrotoxicosis [ICD-11: 5A02] |
Q03181 | PPARD_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q03181 | PPARD_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
Q03181 | PPARD_HUMAN | Autoimmune liver disease [ICD-11: DB96] |
Q03181 | PPARD_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q03181 | PPARD_HUMAN | Obesity [ICD-11: 5B80-5B81] |
Q03181 | PPARD_HUMAN | Alzheimer disease [ICD-11: 8A20] |
Q03181 | PPARD_HUMAN | Dyslipidemia [ICD-11: 5C80-5C81] |
Q03181 | PPARD_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
Q03181 | PPARD_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
Q03181 | PPARD_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P19793 | RXRA_HUMAN | Kaposi sarcoma [ICD-11: 2B57] |
P19793 | RXRA_HUMAN | Mycosis fungoides [ICD-11: 2B01] |
P04637 | P53_HUMAN | Arterial occlusive disease [ICD-11: BD40] |
P04637 | P53_HUMAN | Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] |
P04637 | P53_HUMAN | Metastatic liver/bile duct neoplasm [ICD-11: 2D80] |
P04637 | P53_HUMAN | Transplant rejection [ICD-11: NE84] |
P04637 | P53_HUMAN | Ovarian dysfunction [ICD-11: 5A80] |
P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 | P53_HUMAN | Bladder cancer [ICD-11: 2C94] |
P04637 | P53_HUMAN | Brain cancer [ICD-11: 2A00] |
P04637 | P53_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P04637 | P53_HUMAN | Esophageal cancer [ICD-11: 2B70] |
P04637 | P53_HUMAN | Head and neck cancer [ICD-11: 2D42] |
P04637 | P53_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
P04637 | P53_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P04637 | P53_HUMAN | Ovarian cancer [ICD-11: 2C73] |
P04637 | P53_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 | P53_HUMAN | Stomach cancer [ICD-11: 2B72] |
P04637 | P53_HUMAN | Cervical cancer [ICD-11: 2C77] |
P04637 | P53_HUMAN | Endometrial cancer [ICD-11: 2C76] |
P04637 | P53_HUMAN | Fallopian tube cancer [ICD-11: 2C74] |
P04637 | P53_HUMAN | Liposarcoma [ICD-11: 2B59] |
P04637 | P53_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P04637 | P53_HUMAN | Peritoneal cancer [ICD-11: 2C51] |
P04637 | P53_HUMAN | Toxicity [ICD-11: N.A.] |
P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 | P53_HUMAN | Kidney failure [ICD-11: GB60-GB6Z] |
P04637 | P53_HUMAN | Hearing disorder [ICD-11: AB50-AB57] |